Sidebar

Post-transcriptional events have been recognised as having a significant impact on the behaviour  of the molecular machinery of the cells, inducing selective splicing, mRNA degradation in the cytoplasm and influencing cell fate determination, differentiation and proliferation.  More specifically, the elevated activity of RNA editing and  N6-methyladenosine (m6A), a methyl modification of adenosine, are ubiquitous in cancer cells.

Such post-transcriptional changes can occur anywhere in the transcriptome, however they are  less often  observed within open reading frames (ORF). When coding regions are edited, the aminoacid sequence and the expression of  a protein are altered.

Post-transcriptional m6A is regulated through the activities of “writer”, “reader” and “eraser” genes. Writers catalyse the  methylation; readers recognise the mehylated sites and decide on the fate of the modified mRNA, inducing, e.g., preferential binding to proteins, alternative splicing, post-translational modifications or protein degradation; erasers instead promote loci demethylation.

The advent of direct RNA sequencing, introduced by Oxford Nanopore Technologies (ONT), opens an avenue for the comprehensive, unbiased profiling of post-translational modifications.

The main goal of the Ph.D. is to investigate post-translational modifications cancer cell lines which so far have not been studied  using ONT direct RNA sequencing and to functionally validate the findings using gene editing approaches such as CRISPR screens or interference. 

 

Supervisor:

Dr. Giancarlo Russo

Contacts:

Email:

phone: +37052398249

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies. More information